Case of Enteric Fever with Bicytopenia.
Journal: 2018/November - Cureus
ISSN: 2168-8184
Abstract:
Infectious diseases are one of the major causes of morbidity and mortality in developing countries. Typhoid has its own contribution to the disease burden, especially in Pakistan and other tropical countries. Herein, we present a case of enteric fever with a rare presentation. Our patient is a 20-year-old man who gradually developed high-grade fever lasting seven days associated with rigors and chills. No additional accompanying systemic signs helped to localize the infection. After extensive laboratory testing, his typhoid serology was positive along with leukocytopenia and thrombocytopenia. Typhoid fever is typically associated with either diarrhea or constipation and sphygmothermic dissociation (Faget's sign); our patient did not have these symptoms or signs. As leukocytopenia and thrombocytopenia contribute to mortality and complications, it was necessary to monitor the patient accordingly.
Open in
PUBMED | DOI | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(2)
Similar articles
Articles by the same authors
Discussion board
Cureus 9(12)
PMID: 29441245
PMC: 5800782

Case of Enteric Fever with Bicytopenia

Abstract

Introduction

Typhoid, also known as enteric fever, is a multisystem illness caused most commonly by Salmonella typhi, with symptoms ranging from mild to severe. This disease is typically spread by unsafe water and sanitation in impoverished areas [1]. Despite the use of antibiotics, it remains endemic in developing countries [2]. The usual symptoms are sustained fever, chills, and abdominal pain. Additionally, infected individuals may experience rash, nausea, anorexia, diarrhea or constipation, headache, and/or reduced level of consciousness [3].

Case presentation

A previously healthy 20-year-old man presented to the hospital with a one-week history of remittent high-grade fever (103°F) associated with rigors and chills. The fever cycled daily; it was gradual in onset, settling with antipyretics, but was followed by profuse sweating. Nausea was present, but no episode of vomiting, diarrhea or constipation occurred. The patient provided a history of two weeks with a sore throat. He is a non-alcoholic and nonsmoker with access to clean water. He denied any recent history of contacts with the sick, travel, mosquito bites, weight loss, headache, body aches or pains, bleeding, urinary complaints, or jaundice. On examination, he was febrile and tachycardic, had pale skin, and appeared toxic. Results from his neurological and cardiovascular exams were normal. On abdominal exam, bowel sounds were audible. The abdomen was soft and non-tender, and no hepatosplenomegaly was appreciated. Since there was no localization of infection on history or physical exam, an extensive laboratory workup was done. Only the results of the Typhidot® (immunoglobulin G and M) (Reszon Diagnostics International Sdn. Bhd., Selangor, Malaysia) were positive. Additionally, the test results indicated a very low platelet count of 5,000/µL and a white blood cell (WBC) count of 3,700/µL; it is unusual for enteric fever to cause thrombocytopenia and leukopenia. He was started on antipyretics, antibiotics (azithromycin and meropenem), a proton pump inhibitor, platelet replacement therapy, and packed red blood cells. After treatment, his platelet levels improved to 25,300/µL, and his hemoglobin improved from 7.4 g/dL to 11.3 g/dL in seven days. His complete blood count and complete metabolic profile are shown in Tables 1-2 below.

Table 1
Comparison of Complete Blood Picture at the Time of Presentation and One week After Treatment
At time of presentationOne week after treatment
Red blood cell count4.2 x 106/µL3.6 x 106/µL
White blood cell count3,700/µL7,000/µL
Platelet count5,000/µL25,300/µL
Hemoglobin7.4 g/dL11.3 g/d
Table 2
Comparison of Complete Metabolic Profile at the Time of Presentation and One Week After Treatment
At the time of presentationOne week after treatment
Potassium3.8 mmol/L4.1 mmol/L
Sodium134 mmol/L139 mmol/L
Bilirubin0.7 mg/dL0.7 mg/dl
Alanine aminotransferase36 U/L35 U/L
Alkaline phosphatase119 U/L98 U/L
Creatinine0.1 mg/dL0.7 mg/dL
Urea14 mg/dL15 mg/dL
Glucose118 mg/dL99 mg/dl

Discussion

The annual incidence of typhoid fever was documented as 209/100,000 persons from 1972 to 1973 [4]. Another study showed an incidence of 48/100,000 persons from 1978 to 1981 [5]. Where typhoid is endemic, patients admitted to hospitals are usually between 5 to 25 years of age [3]. As typhoid develops, the predominant symptom is fever. The patient usually has anorexia, nausea, and vomiting; in severe cases, constipation or bloody diarrhea will occur. Mild normocytic normochromic anemia is a common finding [6]. Only 2% of patients had isolated thrombocytopenia, as reported by Serefhanoglu, et al. [7]. In a study conducted by Qamar, et al., cytopenia was found in 98% of enteric fever patients; amongst these, anemia was present in 61.3%, leucopenia in 52%, thrombocytopenia in 39.3%, and thrombocytopenia alone in 2% [8]. A study by Abro, et al. in 2009 found anemia in 61.3%, thrombocytopenia in 40%, leukocytosis in 10.6%, and leucopenia in 4% of the cases reviewed [9]. Another study found leukopenia in 21%, leukocytosis in 2.46%, anemia in 10%, thrombocytopenia in 14.8%, and pancytopenia in 4.93% of the cases reviewed [10]. Our patient had bicytopenia with an extremely low hemoglobin (7.4 g/dL) and platelet count (i.e., 5,000 /µL).

Conclusions

Typhoid fever remains a significant health burden, especially in low- and middle-income countries. Despite the availability of more recent data on enteric fever, additional research is needed in many regions. Enteric fever has variable hematological manifestation, such as anemia and bicytopenia. Early diagnosis and treatment may decrease morbidity and mortality.

References

  • 1. Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areasJ Travel MedWhitakerJAFranco-ParedesCdel RioCEdupugantiS4652162009[PubMed][Google Scholar]
  • 2. Burden of typhoid and paratyphoid fever in a densely populated urban community, Dhaka, BangladeshInt J Infect DisNaheedARamPKBrooksWA099LivingstoneChurchill152010[Google Scholar]
  • 3. Typhoid; clinical analysis of 360 casesArch Intern Med (Chic)StuartBMPullenRL629661781946[PubMed][Google Scholar]
  • 4. Controlled field trial of a typhoid vaccine prepared with a nonmotile mutant of Salmonella Typhi Ty2Bull World Health OrganWahdanMHSippelJEMikhailIA6973521975https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2366336/pdf/bullwho00463-0078.pdf[PubMed][Google Scholar]
  • 5. A controlled field trial of live oral typhoid vaccine Ty21aBull World Health OrganWahdanMHSerieCGermanierR469474581980https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395909/pdf/bullwho00426-0126.pdf[PubMed][Google Scholar]
  • 6. Typhoid FeverPark's Textbook of Preventive and Social Medicine 20th EditionParkK206210BhanotBanarsidas2009https://www.flipkart.com/park-s-textbook-preventive-social-medicine-20th/p/itmdyv7hhgxymv95[Google Scholar]
  • 7. Isolated thrombocytopenia: the presenting finding of typhoid feverClin Lab HaematolSerefhanogluKKayaESevincA6365252003[PubMed][Google Scholar]
  • 8. Hematological changes associated with typhoid feverRawal Med JQamarUAijazJ3235382013https://www.ejmanager.com/mnstemps/27/27-1338812650.pdf[Google Scholar]
  • 9. Hematological and biochemical changes in typhoid feverPak J Med Sci92018AbroAHAbdouAMSGangwaniJL166171252009http://www.pjms.com.pk/issues/aprjun109/article/article1.html[Google Scholar]
  • 10. Profile of culture positive enteric fever from BangaloreMed J Armed Forces IndiaGuptaSHandaAChadhaDS328331652009[PubMed][Google Scholar]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.